CHTN_BRCaProg2 - Breast Cancer Progression

TMA Map

CHTN_BRCaProg2 Breast Cancer Progression TMA Map in a table

Back    Return to top

Code Key

CHTN_BRCaProg2 Breast Cancer Progression Code Key in a Table

Back    Return to top

Tissue List

TMA code Diagnosis Age Race pT stage* pN stage* Estrogen Receptor Progesterone Receptor Her2 Amplification†† Other samples from same subject
NB-NC-1 Non-neoplastic breast from patients without breast carcinoma 19 B N/A N/A N/A N/A N/A  
NB-NC-2 Non-neoplastic breast from patients without breast carcinoma 24 B N/A N/A N/A N/A N/A  
NB-NC-3 Non-neoplastic breast from patients without breast carcinoma 25 W N/A N/A N/A N/A N/A  
NB-NC-4 Non-neoplastic breast from patients without breast carcinoma 26 B N/A N/A N/A N/A N/A  
NB-NC-5 Non-neoplastic breast from patients without breast carcinoma 43 W N/A N/A N/A N/A N/A  
NB-NC-6 Non-neoplastic breast from patients without breast carcinoma 38 B N/A N/A N/A N/A N/A  
NB-NC-7 Non-neoplastic breast from patients without breast carcinoma 23 B N/A N/A N/A N/A N/A  
NB-C-1 Non-neoplastic from breast carcinoma patients 68 W pT1a snpN0 positive positive negative  
NB-C-2 Non-neoplastic from breast carcinoma patients 60 W mpT1c snpN0 positive positive negative  
NB-C-3 Non-neoplastic from breast carcinoma patients 67 W pT2 pN0 positive positive negative ICL-2
NB-C-4 Non-neoplastic from breast carcinoma patients 59 W pT2 pN0 positive positive positive IDC-H-3
NB-C-5 Non-neoplastic from breast carcinoma patients 44   pT1c pN0 positive negative negative  
NB-C-6 Non-neoplastic from breast carcinoma patients 39 W pTis(DCIS)   positive      
NB-C-7 Non-neoplastic from breast carcinoma patients 47 W pT1c snpN0 positive positive negative IDC-L-5
DCIS-L-1 Ductal carcinoma in situ, low grade 60 B pTis(DCIS) snpN0 positive      
DCIS-L-2 Ductal carcinoma in situ, low grade 64 B pTis(DCIS)   positive      
DCIS-L-3 Ductal carcinoma in situ, low grade 43 W pT1b pN0 positive positive negative  
DCIS-L-4 Ductal carcinoma in situ, low grade 43 W pTis(DCIS) snpN0 positive      
DCIS-L-5 Ductal carcinoma in situ, low grade 51 W pT1c snpN0 positive positive negative  
DCIS-L-6 Ductal carcinoma in situ, low grade 54   pTis(DCIS) pNx positive      
DCIS-L-7 Ductal carcinoma in situ, low grade 58 W pTis(DCIS) snpN0 positive positive    
DCIS-H-1 Ductal carcinoma in situ, high grade 48 B pTis(DCIS)   positive      
DCIS-H-2 Ductal carcinoma in situ, high grade 50 W pTis(DCIS)   positive      
DCIS-H-3 Ductal carcinoma in situ, high grade 73 W pTis(DCIS) snpN0 positive      
DCIS-H-4 Ductal carcinoma in situ, high grade 82 B pT2 snpN0 negative negative negative  
DCIS-H-5 Ductal carcinoma in situ, high grade 42 W pT1c pN2a positive positive negative  
DCIS-H-6 Ductal carcinoma in situ, high grade 56 W ypTis(DCIS) ypN0 negative positive positive  
DCIS-H-7 Ductal carcinoma in situ, high grade 37 B pTis(DCIS) pN1a positive positive negative  
IDC-L-1 Invasive ductal carcinoma, grade 1 or 2 57 B pT2 pN0 positive positive positive  
IDC-L-2 Invasive ductal carcinoma, grade 1 or 2 48 W ypT1c pN2a positive negative negative LMN-6
IDC-L-3 Invasive ductal carcinoma, grade 1 or 2 61 W pT1c pN0 positive positive negative  
IDC-L-4 Invasive ductal carcinoma, grade 1 or 2 31 W pT2 snpN0 positive positive negative  
IDC-L-5 Invasive ductal carcinoma, grade 1 or 2 47 B pT1c snpN0 positive positive negative  
IDC-L-6 Invasive ductal carcinoma, grade 1 or 2 48 W pT2 pN2a positive positive negative NB-C-7
IDC-L-7 Invasive ductal carcinoma, grade 1 or 2 70 W pT2 pN3a positive positive negative  
IDC-H-1 Invasive ductal carcinoma, grade 3 58 B ypT2 ypN1a negative negative negative  
IDC-H-2 Invasive ductal carcinoma, grade 3 58 O ypT2 ypN2a positive positive negative LNM-1
IDC-H-3 Invasive ductal carcinoma, grade 3 59 W pT2 pN0 positive positive positive NB-C-4
IDC-H-4 Invasive ductal carcinoma, grade 3 77 W pT3 pN1a positive positive negative  
IDC-H-5 Invasive ductal carcinoma, grade 3 79 W ypT4b ypN1a positive positive positive LNM-7
IDC-H-6 Invasive ductal carcinoma, grade 3 64 W pT1b snpN0 negative negative negative  
IDC-H-7 Invasive ductal carcinoma, grade 3 46 W pT2 pN0 negative negative positive  
ILC-1 Invasive lobular carcinoma 49 W pT1c pN0 positive positive negative  
ILC-2 Invasive lobular carcinoma 67 W pT2 pN0 positive positive negative NB-C-3
ILC-3 Invasive lobular carcinoma 65 W pT2 pN0 positive positive negative  
ILC-4 Invasive lobular carcinoma 64 W pT1c pN1a positive positive negative  
ILC-5 Invasive lobular carcinoma 59 B ypT2 ysnpN0 positive positive negative  
ILC-6 Invasive lobular carcinoma 76 W pT2 pN3a positive negative negative  
ILC-7 Invasive lobular carcinoma 75 W pT1c pN0 positive positive negative  
LNM-1 Breast carcinoma metastatic to regional lymph nodes 58 O ypT2 ypN2a positive positive negative IDC-H-2
LNM-2 Breast carcinoma metastatic to regional lymph nodes 85 W pT4b pN1a positive positive negative  
LNM-3 Breast carcinoma metastatic to regional lymph nodes 39 B pT2 pN2a positive positive negative  
LNM-4 Breast carcinoma metastatic to regional lymph nodes 54 B pT1a pN1a positive positive negative  
LNM-5 Breast carcinoma metastatic to regional lymph nodes 62 W pT1c pN3a negative negative negative  
LNM-6 Breast carcinoma metastatic to regional lymph nodes 48 W pT1c pN2a positive negative negative IDC-L-2
LNM-7 Breast carcinoma metastatic to regional lymph nodes 79 W ypT4b ypN1a positive positive positive IDC-H-5
 
 
  Race: W = white, B = black, O = other non-white
 
  *American Joint Committee on Cancer Cancer Staging Manual, 7th Ed.
 
  ER & PR: negative = <1%+, positive = ≥1%+, blank = not tested
 
  ††Her2: negative = not amplified, positive = amplified, blank = not tested

Back    Return to top